Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Jin

Showing results (341-350 of 356) with videos related to

Pageof 36
Sort By:
Plos One|August 30, 2014
Y chromosomes of 40% Chinese descend from three Neolithic super-grandfathersShi Yan, Chuan-Chao Wang, Hong-Xiang Zheng, et al.
Human Vaccines & Immunotherapeutics|October 16, 2023
Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trialZhi-Wei Wu, Fei Jin, Qing-Liang Li, et al.
International Journal of Antimicrobial Agents|November 26, 2018
Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infantsHui Qi, Chen Kou, Yu-Jie Qi, et al.
Nature Communications|December 2, 2025
Understanding interspecies drug response variations between human and rodent P2X7 receptorsChang-Run Guo, Danqi Sheng, Ji-Yuan Li, et al.
Vaccine|June 27, 2024
Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographicFei Jin, Lei Zhu, Yunpeng Wang, et al.
Plos Biology|April 27, 2021
The structure of MgtE in the absence of magnesium provides new insights into channel gatingFei Jin, Minxuan Sun, Takashi Fujii, et al.
Expert Review of Vaccines|September 1, 2022
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and aboveZhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, et al.
Vaccine|February 16, 2024
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trialFei Jin, Yuanzheng Qiu, Zhiwei Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 5, 2021
Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsisXue Li, Hui Qi, Fei Jin, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trialPeng-Fei Jin, Xi-Ling Guo, Jin-Bo Gou, et al.
Pageof 36

Showing results (341-350 of 356) with videos related to

Sort By:
Pageof 36
Plos One|August 30, 2014
Y chromosomes of 40% Chinese descend from three Neolithic super-grandfathersShi Yan, Chuan-Chao Wang, Hong-Xiang Zheng, et al.
Human Vaccines & Immunotherapeutics|October 16, 2023
Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trialZhi-Wei Wu, Fei Jin, Qing-Liang Li, et al.
International Journal of Antimicrobial Agents|November 26, 2018
Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infantsHui Qi, Chen Kou, Yu-Jie Qi, et al.
Nature Communications|December 2, 2025
Understanding interspecies drug response variations between human and rodent P2X7 receptorsChang-Run Guo, Danqi Sheng, Ji-Yuan Li, et al.
Vaccine|June 27, 2024
Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographicFei Jin, Lei Zhu, Yunpeng Wang, et al.
Plos Biology|April 27, 2021
The structure of MgtE in the absence of magnesium provides new insights into channel gatingFei Jin, Minxuan Sun, Takashi Fujii, et al.
Expert Review of Vaccines|September 1, 2022
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and aboveZhuo-Pei Li, Yun-Feng Shi, Li-Hua Hou, et al.
Vaccine|February 16, 2024
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trialFei Jin, Yuanzheng Qiu, Zhiwei Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 5, 2021
Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsisXue Li, Hui Qi, Fei Jin, et al.
The Lancet Regional Health. Western Pacific|June 26, 2023
Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trialPeng-Fei Jin, Xi-Ling Guo, Jin-Bo Gou, et al.
Pageof 36